Aurobindo Pharma Ltd
NSE:AUROPHARMA

Watchlist Manager
Aurobindo Pharma Ltd Logo
Aurobindo Pharma Ltd
NSE:AUROPHARMA
Watchlist
Price: 1 105.35 INR -5.96% Market Closed
Market Cap: 642B INR

Intrinsic Value

The intrinsic value of one AUROPHARMA stock under the Base Case scenario is 1 140.77 INR. Compared to the current market price of 1 105.35 INR, Aurobindo Pharma Ltd is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AUROPHARMA Intrinsic Value
1 140.77 INR
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Aurobindo Pharma Ltd

AUROPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AUROPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Aurobindo Pharma Ltd
NSE:AUROPHARMA
IN
Pharmaceuticals
Market Cap
642B INR
IPO
Jan 19, 1995
IN
Pharmaceuticals
Market Cap
642B INR
IPO
Jan 19, 1995
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AUROPHARMA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aurobindo Pharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aurobindo Pharma Ltd

Current Assets 262.3B
Cash & Short-Term Investments 75.2B
Receivables 54B
Other Current Assets 133B
Non-Current Assets 218.7B
Long-Term Investments 8.1B
PP&E 149.2B
Intangibles 40.1B
Other Non-Current Assets 21.3B
Efficiency

Free Cash Flow Analysis
Aurobindo Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aurobindo Pharma Ltd

Revenue
309.2B INR
Cost of Revenue
-126.6B INR
Gross Profit
182.6B INR
Operating Expenses
-133.2B INR
Operating Income
49.4B INR
Other Expenses
-14.5B INR
Net Income
34.9B INR
Fundamental Scores

AUROPHARMA Profitability Score
Profitability Due Diligence

Aurobindo Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
55/100
Profitability
Score

Aurobindo Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

AUROPHARMA Solvency Score
Solvency Due Diligence

Aurobindo Pharma Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

81/100
Solvency
Score

Aurobindo Pharma Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUROPHARMA Price Targets Summary
Aurobindo Pharma Ltd

Wall Street analysts forecast AUROPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUROPHARMA is 1 505.91 INR with a low forecast of 1 151.4 INR and a high forecast of 2 026.5 INR.

Lowest
Price Target
1 151.4 INR
4% Upside
Average
Price Target
1 505.91 INR
36% Upside
Highest
Price Target
2 026.5 INR
83% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AUROPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AUROPHARMA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AUROPHARMA stock?

The intrinsic value of one AUROPHARMA stock under the Base Case scenario is 1 140.77 INR.

Is AUROPHARMA stock undervalued or overvalued?

Compared to the current market price of 1 105.35 INR, Aurobindo Pharma Ltd is Undervalued by 3%.

Back to Top